Latest / Bloomberg Intelligence / Kodak Craziness Is Captured in One Word. Really?: Max Nisen
Transcript
- 0:01Speaker 1: Welcome to the Bloomberg Markets Podcast. I'm Paul Sweeney, along
- 0:04Speaker 1: with my co host of Bonnie Quinn. Every business day
- 0:06Speaker 1: we bring you interviews from CEOs, market pros, and Bloomberg experts,
- 0:10Speaker 1: along with essential market moving news. Kind the Bloomberg Markets
- 0:13Speaker 1: Podcast on Apple Podcasts or wherever you listen to podcasts,
- 0:17Speaker 1: and on Bloomberg dot com. It is time for Bloomberg Opinion.
- 0:22Speaker 1: This morning. We're joined by Bloomberg Opinion columust Max Neson.
- 0:25Speaker 1: He covers all things biotech, farmer and healthcare. Max, You've
- 0:29Speaker 1: got a column now which I just read talking about Kodak.
- 0:32Speaker 1: I'm looking at the shares of Kodak here up twelve
- 0:37Speaker 1: percent today, um up seven year to date, up over
- 0:43Speaker 1: the trailing twelve months, and now has a market cap
- 0:45Speaker 1: of one point six three billion. I didn't even know
- 0:47Speaker 1: this company was still in existence as a public equity.
- 0:51Speaker 1: What's going on with Kodak? Uh? So, what's going on
- 0:55Speaker 1: driving this this incredible stuff? Brice Increase is a deal
- 1:01Speaker 1: alan from from the government which is intended to help
- 1:05Speaker 1: them kind of make a transition into into a new business,
- 1:09Speaker 1: uh which is the making of of drug product of
- 1:13Speaker 1: of active pharmaceutical ingredients part of kind of an ongoing
- 1:17Speaker 1: policy effort to bring more of that production back into
- 1:22Speaker 1: the United States. UM, which you know that that business
- 1:26Speaker 1: is really currently very dependent on China and India. I'm
- 1:30Speaker 1: in addition to the sort of political leanings of the
- 1:33Speaker 1: current administration. You know, there are potential national security concerns
- 1:37Speaker 1: about disruption, there have been quality control issues, so you know,
- 1:40Speaker 1: it's not a not an insane policy move. But but
- 1:44Speaker 1: the thing that's a little bit more difficult to understand
- 1:47Speaker 1: is why Kodak and secondly, um, why why this loan
- 1:53Speaker 1: well significant would lead to such an enormous increase in
- 1:56Speaker 1: the stock Because this is a company that that, while
- 1:59Speaker 1: it has chemical experience, is new to this business, which
- 2:03Speaker 1: is a very difficult, very low margin commodity business. It
- 2:08Speaker 1: moved out the United States for a reason because it's
- 2:11Speaker 1: much cheaper to do it elsewhere. It's hard to be
- 2:13Speaker 1: cost competitive here. So the imagined future where you know,
- 2:18Speaker 1: code Act does this sustainably and profitably seems very unlikely
- 2:23Speaker 1: to mean, I just want to bring it to our
- 2:25Speaker 1: listeners attention that several outlets and now reporting that Hermann Kine,
- 2:29Speaker 1: the former presidential candidate has died from COVID nineteen once again,
- 2:33Speaker 1: Herman Caine has died from COVID nineteen. Will bring you
- 2:37Speaker 1: more details when we get them. But another death among
- 2:41Speaker 1: the one d and fifty thousand plus deaths that we
- 2:44Speaker 1: were counting every day, Max. How concerning is that that
- 2:47Speaker 1: we are seeing numbers rise again in the places like
- 2:51Speaker 1: New Jersey, which had tried to sort of Tampa down
- 2:54Speaker 1: and had managed to do so. It's it's very concerning,
- 2:59Speaker 1: and you know, unfortunately maybe inevitable accent uh you know,
- 3:04Speaker 1: really really strict policy or or you know, profound adherent
- 3:09Speaker 1: to social distancing guidelines going forward. I think the country
- 3:14Speaker 1: is in a pretty concerning place where well, you do
- 3:17Speaker 1: have some some plateauing or or decline of case growth
- 3:23Speaker 1: in you know, put the initial hotspots Texas, initial new offspots, Texas, Florida, Arizona.
- 3:28Speaker 1: You still have many cases there also deaths as as
- 3:33Speaker 1: you know, people have consistently warned catching up to that
- 3:36Speaker 1: case you know, that past case growth, and then many
- 3:39Speaker 1: other examples besides New Jersey around the country that you know,
- 3:42Speaker 1: well not as acute as those hot spots, yet still
- 3:46Speaker 1: seeing very significant levels of case growth. All of which um,
- 3:50Speaker 1: you know, makes any further opening, makes school in the
- 3:53Speaker 1: fall harder and will lead to both you know, more
- 3:56Speaker 1: debts and the sort of unknown long term consequences of infection. Um,
- 4:01Speaker 1: which you know, more more research props up every day
- 4:04Speaker 1: indicating the possibility of heart lung damage that may be durable.
- 4:09Speaker 1: So um, yeah, it's a it's a scary time, all right.
- 4:12Speaker 1: So that brings us to the continuing ongoing view of
- 4:16Speaker 1: potential for vaccines Johnson and Johnson. I saw a headline
- 4:20Speaker 1: vaccine protects monkeys from COVID with single shot. How important
- 4:25Speaker 1: is the J and j H news there? Um, you know,
- 4:29Speaker 1: it's a little bit of both. Do you always have
- 4:31Speaker 1: to be particularly cautious about um, you know, non human data.
- 4:37Speaker 1: There's a saying among people who do in vectious disease research, Um,
- 4:40Speaker 1: you know, mice lie, monkeys exaggerate, So you know, there,
- 4:44Speaker 1: there's that's a thing you really kind of do have
- 4:46Speaker 1: to view it in the context that, well, well, this
- 4:49Speaker 1: can tell you something valuable, give you an indication of
- 4:51Speaker 1: the likelihood that a vaccine is promising, and in this case,
- 4:55Speaker 1: the particularly promising potential of of a single dose. After
- 5:00Speaker 1: you really do need to see it at humans before
- 5:03Speaker 1: you make any conclusions. And that's something where um, you know,
- 5:07Speaker 1: the change of vaccine is running a little bit behind.
- 5:09Speaker 1: It just began it its first in human studies, so
- 5:13Speaker 1: I'll I personally wait for that before making to two
- 5:16Speaker 1: firm of a verdict on the promise of the vaccine. Though, um,
- 5:20Speaker 1: definitely you know what you want to see from a
- 5:22Speaker 1: primary challenge study. You know it wasn't It went well
- 5:26Speaker 1: within the limitations of the study. And we have confirmation
- 5:29Speaker 1: now on the Boomberg website that Herman Came, the piece
- 5:32Speaker 1: of Jane executive of course, has died seventy four years old.
- 5:36Speaker 1: He released a statement via Twitter on July twod that
- 5:40Speaker 1: he was hospitalized in the Atlanta area after contracting coronavirus,
- 5:44Speaker 1: and that was less than two weeks after attending President
- 5:47Speaker 1: Donald Thomp's indoor rally and Tulsa, Arizona. He didn't know
- 5:50Speaker 1: when or how he contracted the disease. But again, Herman Kine,
- 5:54Speaker 1: the former prominent Republican who actually was running for White
- 6:00Speaker 1: House position, if you'd like to put it that way,
- 6:03Speaker 1: has died from COVID nineteen Max. Thank you, This isn't
- 6:07Speaker 1: the last death, unfortunately from this awful pandemic. And again
- 6:11Speaker 1: we're more than a hundred and fifty thousand people down
- 6:14Speaker 1: here in the United States now and much more than
- 6:16Speaker 1: that globally, so Paul and another prominent figure dying from
- 6:21Speaker 1: COVID nineteen. You have to wonder if this will change
- 6:23Speaker 1: the conversation in any way across the country, but unfortunately
- 6:27Speaker 1: it's hard to see that happening. It is time to
- 6:31Speaker 1: take a closer look at that economic data as well
- 6:33Speaker 1: as what the Federal Reserved chair said yesterday. No better
- 6:36Speaker 1: man than to bring in David Kotok Now of Cumberland Advisors. David,
- 6:41Speaker 1: good morning, and welcome. Good morning, Vanney. It's nice to
- 6:44Speaker 1: talk with well, it is, except that we got a
- 6:48Speaker 1: second quarter annualized figure of down thirty two point nine
- 6:54Speaker 1: percent for GDP growth. What does that mean for the
- 6:57Speaker 1: economy going forward? What should we read into this well
- 7:01Speaker 1: remarkable number. We've already had a lot of conversation about it.
- 7:05Speaker 1: Um it was expected to be huge, and it validated
- 7:10Speaker 1: the expectation, and it says nothing about where we're going
- 7:15Speaker 1: to be in the fourth quarter and next year. And
- 7:19Speaker 1: that's what's key markets are I think are reacting not
- 7:24Speaker 1: to the GDP number with this red tape today. I
- 7:27Speaker 1: think they're reacting to the impasse from the US Congress,
- 7:31Speaker 1: which invites risk and the blame game between the two
- 7:35Speaker 1: largest economies in the world, China and the United States.
- 7:39Speaker 1: And I think that's what's driving this market to a
- 7:41Speaker 1: red tape, not GDP. All right, Dave, let's let's go there. Um.
- 7:46Speaker 1: We had Kevin Sirelli, Bloomberg's Washington correspondent on earlier with
- 7:50Speaker 1: Tom Keene and myself on surveillance. He believes that from
- 7:54Speaker 1: his contacts in Washington that something will in fact get
- 7:57Speaker 1: done this week. What's your outlook for the fiscal stimulus?
- 8:01Speaker 1: What do you think the market is really looking for
- 8:03Speaker 1: to come out of Washington. Yeah, well, I I saw
- 8:06Speaker 1: the piece with Kevin. Um. As you said, you know,
- 8:09Speaker 1: I'm a regular surveillance watcher every morning, and I think
- 8:14Speaker 1: the cutting edges where they're going to meet in the middle.
- 8:17Speaker 1: The issue of the liabilities is not resolved, or maybe
- 8:22Speaker 1: it will become. So how do you deal with a
- 8:25Speaker 1: retroactive liability deletion on the part of local governments, on
- 8:30Speaker 1: the part of business. Is what to do with the
- 8:32Speaker 1: liability for COVID and how do you establish proof in
- 8:35Speaker 1: a pandemic. These are also complicated my expectation as the
- 8:40Speaker 1: markets would like to see you meet in the middle compromise.
- 8:43Speaker 1: They don't expect three plus trillion, and they don't expect
- 8:46Speaker 1: one trillion, and they do expect some amount of sustenance
- 8:51Speaker 1: to keep thirty or forty million Americans bridged at least
- 8:56Speaker 1: in part across the gap for the rest of the year.
- 9:00Speaker 1: Markets would like that, businesses would like that, the citizens
- 9:03Speaker 1: would like that, and we would get beyond the same
- 9:05Speaker 1: pass which you indicated this morning is possibly going to happen.
- 9:10Speaker 1: Is it realistate, David to think though, that, you know,
- 9:14Speaker 1: the administration of all of this can get done in
- 9:17Speaker 1: the way that Republicans are expecting, in the sense of,
- 9:20Speaker 1: you know, okay, down to two extra from the federal
- 9:23Speaker 1: governments per week for a couple of months, and then
- 9:25Speaker 1: you know, by then everybody will be able to get
- 9:28Speaker 1: some of what they had been making. Is that even possible?
- 9:31Speaker 1: There is no extra money for states to do this? Um, well,
- 9:35Speaker 1: that's that's the profound question, Ronnie. It's a fair one,
- 9:39Speaker 1: you know. I I reflect on history as you know it.
- 9:43Speaker 1: I'm a student of history for a very long time.
- 9:46Speaker 1: And I remember Winston Churchill rising in the House of Commons.
- 9:50Speaker 1: I wasn't there at the time when I'm very young,
- 9:52Speaker 1: but I remember reading his words in in the House
- 9:56Speaker 1: of Commons after World War two and all the chaos
- 9:59Speaker 1: a allowed, and he stood up in the House of
- 10:01Speaker 1: Commons and he says, it has been said that democracy
- 10:05Speaker 1: is the worst system of government. And he paused, and
- 10:10Speaker 1: he said, except for all the others. And we are
- 10:14Speaker 1: testing Churchill's wisdom right now today in the United States,
- 10:18Speaker 1: as we have been all year. There's truth that that's
- 10:21Speaker 1: our system. As crazy as it is, it's still better
- 10:25Speaker 1: than a place where you live under a dictator and
- 10:27Speaker 1: an autocrat and you have no rights. And so I
- 10:31Speaker 1: I'm a long term believer in this enduring, marvelous experiment
- 10:37Speaker 1: that started over two hundred years ago. So I think
- 10:41Speaker 1: we'll work this out the hard way, but we'll get there. So, David,
- 10:45Speaker 1: what's an investor to do here? As we look at
- 10:48Speaker 1: these dire economic data. Yes, it's backward looking, but it's
- 10:53Speaker 1: really sobering. What should investors do here as they think
- 10:56Speaker 1: about the next of all eighteen months? One investor should do.
- 11:00Speaker 1: It depends on their point of view. In Cumberland's case,
- 11:04Speaker 1: in the stock market, we have some cash reserve, but
- 11:07Speaker 1: we are invested. In the U S stock market, we
- 11:10Speaker 1: are overweight the sectors which we think benefit healthcare. It's
- 11:14Speaker 1: a great example, of course, and we are underweight or
- 11:17Speaker 1: avoiding the troubled places. Trying to pick the right cruise
- 11:21Speaker 1: ship company that will survive is trying to avoid a
- 11:24Speaker 1: falling knife. Why why do that? In the rest of
- 11:27Speaker 1: the world, we are deploying moneys because we think pandemics
- 11:31Speaker 1: run their course. And in Asian countries specifically, we see
- 11:36Speaker 1: the ability of governments to respond better than we have done,
- 11:41Speaker 1: and they are doing that. Why they learned with two
- 11:45Speaker 1: two thousand and three with stars, They prepared, they have
- 11:49Speaker 1: tracing testing, they have all the facilities in place, they
- 11:52Speaker 1: apply technology, they have apps on their phones, whether it's
- 11:56Speaker 1: in a country like China or it's in South Korea,
- 11:59Speaker 1: tai one. So we favor looking at Asian recovery leading
- 12:05Speaker 1: the way coming out of this, and some are already
- 12:08Speaker 1: doing it. And in the United States, we have to
- 12:11Speaker 1: get through this forest fire in the country. Now we
- 12:13Speaker 1: don't have three ways. We don't have flattening the curve.
- 12:16Speaker 1: We have a forest fire. It's burning. It doesn't burn forever,
- 12:21Speaker 1: but it will burn for a while. David, thanks so
- 12:24Speaker 1: much for that. We really appreciate it. David Kotok, Chairman
- 12:27Speaker 1: and Chief investment Officer of Cumberland Advisors. They have over
- 12:30Speaker 1: three billion dollars in assets under mention. We always appreciate
- 12:33Speaker 1: Dave's perspective as broad perspective on the and uh, you know,
- 12:36Speaker 1: putting things in context. I think for investors, I think
- 12:39Speaker 1: that's investor's value that David has seen a few of these.
- 12:43Speaker 1: He's seen pandemics, he has seen crises, he's seen crisis
- 12:46Speaker 1: calls by all different sorts of things. He's seen market
- 12:49Speaker 1: bubbles burst, and he's in the game more than ever.
- 12:53Speaker 1: So obviously there is another side to the end of
- 12:57Speaker 1: all of this. Very excited to welcome our next guest.
- 13:02Speaker 1: Dr David S. Gorton is cardiologist and President and CEO
- 13:06Speaker 1: of the Association of American Medical Colleges or the a
- 13:09Speaker 1: a m C. He joins US now from Washington, d C.
- 13:13Speaker 1: Following an op ed in the Washington Post which was
- 13:16Speaker 1: entitled we need a COVID nineteen reset. So we developed
- 13:19Speaker 1: a comprehensive plan to do just that. Drs Gorton, thanks
- 13:23Speaker 1: for joining. What does a reset look like? Is it
- 13:26Speaker 1: a countrywide lockdown? No, Bunny, First of all, thanks for
- 13:30Speaker 1: having me on UM. It's more complicated than that. We
- 13:34Speaker 1: laid out nine immediate steps that we believe the country
- 13:38Speaker 1: needs to take in two longer term actions. And among
- 13:41Speaker 1: those nine steps, the big three are will not surprise you.
- 13:45Speaker 1: Number one is to do a better job at making
- 13:47Speaker 1: sure that we have the supplies we need from personal
- 13:51Speaker 1: protective equipment to the lab supplies that will allow us
- 13:54Speaker 1: to boost up testing. Number two is testing itself and
- 13:58Speaker 1: really nothing else that we can do in the country
- 14:01Speaker 1: that we want to do, like reopen the economy, go
- 14:03Speaker 1: back to school, go back to college, all of those
- 14:06Speaker 1: things will depend on a better ability to do testing
- 14:09Speaker 1: and turn it around more quickly than we're doing it
- 14:12Speaker 1: right now. And then, thirdly, we believe there should be
- 14:15Speaker 1: national standards on face coverings and that masks should be
- 14:19Speaker 1: mandatory in areas of growing community spread. And then there's
- 14:22Speaker 1: many other aspects, but those are those are the ones
- 14:25Speaker 1: that I believe are the most urgent we need to
- 14:27Speaker 1: work on now. Doctor, I guess For me, the biggest
- 14:30Speaker 1: frustration is that petas I look at the US relative
- 14:33Speaker 1: to other countries around the world, there has not been
- 14:36Speaker 1: a national response policy to what is clearly a national problem.
- 14:43Speaker 1: It is left to state by states. Some states like
- 14:46Speaker 1: New York have done it better than some other states
- 14:48Speaker 1: like Florida for example. Will there ever be a national response?
- 14:54Speaker 1: And if there is, where does it need to come from?
- 14:56Speaker 1: Doesn't need to come from the White House? Well, when
- 14:59Speaker 1: you ask whether ever be a national response, if I
- 15:02Speaker 1: had that crystal ball and it was as effective as that,
- 15:04Speaker 1: I'd probably be um sitting in your seat and telling
- 15:06Speaker 1: people which way to go. But um, what I would
- 15:10Speaker 1: say is the first two words of my outbed and
- 15:13Speaker 1: yesterday's post. We're we're failing, and I mean we very sincerely.
- 15:18Speaker 1: All of us need to pull together individual decisions like
- 15:21Speaker 1: whether to wear a mask, whether to be socially distant,
- 15:24Speaker 1: whether to pay attention to the evidence based advice we're
- 15:27Speaker 1: getting from the top health professionals in the country. And yes,
- 15:31Speaker 1: we believe that there is a role for government to
- 15:34Speaker 1: develop more national policies, not only the administration, Congress, but
- 15:39Speaker 1: there's also a role for the private sector. We think
- 15:41Speaker 1: that the manufacturing sector, for example, could help us. But
- 15:45Speaker 1: we're playing catch up on these supply issues. So there's
- 15:48Speaker 1: something here from everybody. But yes, there does need to
- 15:50Speaker 1: be a national view of how to go forward, and
- 15:53Speaker 1: we try to present that view in our roadmap. Is
- 15:57Speaker 1: there a time limit for this? I mean, will there
- 15:59Speaker 1: be a point beyond which of all is lost? I
- 16:03Speaker 1: don't mean to be, you know, totally apocalyptic about this,
- 16:06Speaker 1: but you know at a certain point it's too late
- 16:08Speaker 1: to implement proactive measures. Well, I'm a physician as scientist,
- 16:14Speaker 1: and I'm very very strong believer in biomedical research. Right
- 16:17Speaker 1: this minute, Bunny and Paul, there are people all over
- 16:20Speaker 1: the world working on robust vaccines right this minute. There's
- 16:24Speaker 1: people at universities and in pharmaceutical industry working on anti
- 16:29Speaker 1: viral treatments and so on. And as we've learned more
- 16:33Speaker 1: about the coronavirus on the front lines of hospitals across
- 16:36Speaker 1: the world, we've learned more and more how to provide
- 16:39Speaker 1: supportive care. So I remain an optimist about this. Nonetheless,
- 16:43Speaker 1: if we don't make some changes and soon in supplies, testing,
- 16:48Speaker 1: face coverings, and some other areas, um we're going to
- 16:52Speaker 1: have a lot more deaths, and I'd like to just
- 16:54Speaker 1: insert one issue relate to finance, if I might. One
- 16:58Speaker 1: of the difficulties of national system of health insurance that's
- 17:02Speaker 1: or fifty percent of people insured through their employer. Is
- 17:06Speaker 1: it a time where employment dips than healthcare coverage dips
- 17:09Speaker 1: as well. And one of our immediate action recommendations is
- 17:13Speaker 1: to immediately expand health insurance through COBRA. That's a mechanism
- 17:18Speaker 1: already in place, but many workers cannot afford to pay
- 17:22Speaker 1: both the employer and employee premiums for COBRA when they're
- 17:25Speaker 1: out of work. So we're asking for Congress to consider
- 17:29Speaker 1: at least partly subsidizing COBRA for a while while we're
- 17:34Speaker 1: in such a pickle in terms of employment and a
- 17:36Speaker 1: reduction in health insurance coverage. Doctor, One of the big
- 17:40Speaker 1: topics right now as it relates to our response to
- 17:44Speaker 1: the pandemic is the reopening of schools or weeks away
- 17:48Speaker 1: in many parts of the country. Many parts of country
- 17:50Speaker 1: are actually reopening now. How do you think this should
- 17:54Speaker 1: play out? One of our recommendations is to establish Tavanni's
- 17:58Speaker 1: point earlier national criteria and your point national criteria for
- 18:03Speaker 1: CAPE through twelve school reopenings and to immediately convene a
- 18:07Speaker 1: working group to study different approaches, so to bring together
- 18:10Speaker 1: the expertise to do this right. We need to bring
- 18:13Speaker 1: the educators, the teachers, We need to bring some voice
- 18:18Speaker 1: from parents and families, and of course we need to
- 18:20Speaker 1: bring the voice of public health, epidemiology and infectious diseases.
- 18:25Speaker 1: There was a recent of consensus report that I commend
- 18:29Speaker 1: to you and your listeners from the National Academy of Science, Engineering,
- 18:32Speaker 1: and Medicine just a few weeks ago, which laid out
- 18:36Speaker 1: a very important step by step process for reopening and
- 18:40Speaker 1: so we have a bit of a roadmap from the
- 18:42Speaker 1: National Academy is one of the most prestigious groups in
- 18:45Speaker 1: the country or in the world, and I think we
- 18:47Speaker 1: need to do is make up a national commitment to
- 18:50Speaker 1: listening to some of these recommendations, and then it has
- 18:54Speaker 1: to be interpreted like everything else locally, depending on the
- 18:57Speaker 1: amount of community spread, the re sources available, and the
- 19:01Speaker 1: different neighborhoods of school districts we're talking about. There's a great,
- 19:05Speaker 1: great difference, as you know, in the resources available to
- 19:08Speaker 1: school districts based on local property tax revenue and so on.
- 19:13Speaker 1: So yes, we need to pay attention to this, and
- 19:15Speaker 1: the National Academy's report is a terrific place to start. Dr.
- 19:19Speaker 1: You're a cardiologist as well as everything else, and I'm
- 19:22Speaker 1: curious as to what's been the most surprising thing for
- 19:25Speaker 1: you as a result of this COVID pandemic. What does
- 19:28Speaker 1: the disease do in terms of what you're a specialist
- 19:31Speaker 1: in that terrifies you. Well, um, from the cardiology point
- 19:37Speaker 1: of view, that has not been as prominent as issues
- 19:40Speaker 1: as you know, with the lungs, with the neurological system
- 19:43Speaker 1: and other things. But I'll say as just a physician
- 19:46Speaker 1: in general, I used to run a division of general
- 19:48Speaker 1: internal medicine. We call this a novel coronavirus because it's
- 19:52Speaker 1: the first time that we've known about this coronavirus affecting humans,
- 19:57Speaker 1: and the fact that there can be such robust spread
- 19:59Speaker 1: of a disease from asymptomatic people is quite unusual. And
- 20:04Speaker 1: of course this makes it much much harder to manage
- 20:08Speaker 1: the communities because you don't really know who's got it.
- 20:12Speaker 1: A medical commentator a couple of three months ago said
- 20:15Speaker 1: we should all act as if we have coronavirus. Put
- 20:19Speaker 1: a mask on, stay away from other people, and so
- 20:22Speaker 1: on and so forth, except those in our immediate family
- 20:24Speaker 1: with whom we're living. And I think that's a very
- 20:27Speaker 1: interesting way to look at it. But that's been a big,
- 20:30Speaker 1: big surprise. And then the other big, big surprise has
- 20:33Speaker 1: been the chameleon like effects of this virus on various
- 20:37Speaker 1: different bodily systems. And I'm sure you all have followed
- 20:40Speaker 1: the lingering effects, the neurological effects, as well as those
- 20:43Speaker 1: effects from the immune system on the lungs. He does.
- 20:48Speaker 1: Dr David Scorton, thank you so much for joining us.
- 20:50Speaker 1: We really appreciate your thoughts, uh and opinions, David. Dr
- 20:54Speaker 1: David Scorton, cardiologists and President CEO of the Association of
- 20:57Speaker 1: American Medical Colleges, giving us his thoughts on what a
- 21:00Speaker 1: national policy could look like. Well, tech analysts and tech
- 21:06Speaker 1: investors are going to be more than busy after the
- 21:09Speaker 1: close today. We have the big four tech companies, Apple, Amazon, Facebook,
- 21:13Speaker 1: and Alphabet reporting numbers. I don't think that's ever happened,
- 21:18Speaker 1: Vonnie one time at the same time on the same
- 21:20Speaker 1: day reporting. It's gonna go. So there's gonna be a
- 21:23Speaker 1: lot to pass through from big tech. It's got a
- 21:25Speaker 1: little bit of a preview there. We can do that
- 21:27Speaker 1: with Barry Ridholtz. He's a Bloomberg opinion columnist and host
- 21:30Speaker 1: of Masters in Business on Bloomberg Radio. And of course
- 21:33Speaker 1: he's a founder, chairman and chief investment off Server it
- 21:35Speaker 1: holds wealth Management. So, Barry, if you needed some color
- 21:39Speaker 1: on what's going on in the tech space, I think
- 21:41Speaker 1: you're gonna get it. After the close today, You're gonna
- 21:44Speaker 1: get a lot more than color. You're gonna have a
- 21:46Speaker 1: full painting as to how four of the six companies
- 21:51Speaker 1: that have been driving two thirds of the SMP five hundred,
- 21:56Speaker 1: how well they're doing. And uh, it's gonna be interesting.
- 22:00Speaker 1: Remember back in February, Apple was the first company that
- 22:05Speaker 1: came out and said, given this nascent coronavirus pandemic, we
- 22:10Speaker 1: have no visibility for the rest of the year. They
- 22:13Speaker 1: were way ahead of the curve on that. I'm really
- 22:15Speaker 1: curious to see what they're going to come out and say, Yeah,
- 22:19Speaker 1: it's gonna be fascinating. I mean, will they all show
- 22:22Speaker 1: stellar results? You think Pario it feels like they are
- 22:25Speaker 1: some of the only winners out of all of this. Well,
- 22:28Speaker 1: they clearly have been UM part of the stocks that
- 22:33Speaker 1: have been been driving games. Take take the ten biggest
- 22:37Speaker 1: names in the SMP five hundred on an equal weight basis,
- 22:41Speaker 1: they're up thirty four percent for the year. Take the
- 22:44Speaker 1: next four hundred nine UM stocks in the SNP five
- 22:49Speaker 1: hundred on an equal weight basis, they're down eight percent
- 22:53Speaker 1: for the year. So the the earnings health of the
- 22:58Speaker 1: of the fang so called fang stocks are really important,
- 23:01Speaker 1: but I don't know if investors are going to give
- 23:03Speaker 1: them a pass. If anybody says, well, this sector did
- 23:08Speaker 1: well and this division did well, but we really saw
- 23:11Speaker 1: soft sales in this sector. Maybe it's iPhones, maybe it's UM.
- 23:18Speaker 1: Some form of advertising on Facebook or Google that's they
- 23:21Speaker 1: expect will return once things get back to normal. It's interesting.
- 23:26Speaker 1: I'm looking, you know, just at the the advertising driven
- 23:29Speaker 1: names that we're gonna hear from tonight, in terms of
- 23:31Speaker 1: Facebook and and Google parent is alphabet UM those stocks,
- 23:36Speaker 1: you know, they're you know, and also looking for a
- 23:38Speaker 1: significantly slower rubbnue growth because let's face it, advertisers aren't
- 23:42Speaker 1: advertising that much. I don't care if it's on a
- 23:45Speaker 1: radio or TV ed or a newspaper or on the Internet.
- 23:48Speaker 1: Yet those stocks are still up their team percent. So
- 23:50Speaker 1: I guess tech investors barrier, you know, willing to look
- 23:53Speaker 1: towards the other side of this. Yeah, I mean everybody
- 23:55Speaker 1: knows your your movies aren't advertising, restaurants aren't advertising anything.
- 24:00Speaker 1: That's a face to face experience where people have a
- 24:05Speaker 1: tendency to um put that on hold until we get
- 24:09Speaker 1: past the pandemic. Obviously that's down. I have to think
- 24:15Speaker 1: investors understand that, and they're looking at one maybe even
- 24:20Speaker 1: past that too. It's it's hard to It's really hard
- 24:24Speaker 1: to say. And one of the bigger concerns was regulatory
- 24:29Speaker 1: overreach in d C. Based on what we saw yesterday,
- 24:33Speaker 1: I don't think these four companies have a whole lot
- 24:36Speaker 1: to worry about in terms of the government figuring out
- 24:40Speaker 1: what they even do more or less regulating them or
- 24:43Speaker 1: breaking them up. Sorry, I mean, is this the line
- 24:47Speaker 1: of the sound after this? If there are no consequences
- 24:51Speaker 1: in any way regulatory or anti trust or otherwise, do
- 24:55Speaker 1: they get Carton Lush and do we see somebody like
- 24:58Speaker 1: Jeff Bezos and start increasing prices on Amazon, which was
- 25:01Speaker 1: always the original goal anyway, you know, the only historical
- 25:06Speaker 1: frame of reference that that I can compare this to
- 25:10Speaker 1: was Microsoft in the late nineties, and if you remember,
- 25:13Speaker 1: Microsoft owned the desktop, and any time a new idea
- 25:19Speaker 1: or feature or a little software program was developed, it
- 25:23Speaker 1: managed to be copied and built into Windows. And once
- 25:27Speaker 1: the Justice Department started talking about antitrust enforcement, it really
- 25:33Speaker 1: led to that Cambrian explosion of websites and soft web
- 25:38Speaker 1: based software apps. And I'm wondering if something similar might
- 25:43Speaker 1: not happen. Maybe we're at peak Google and peak Facebook.
- 25:47Speaker 1: Given the mere fact that we're having this hearing, Microsoft
- 25:52Speaker 1: might have, you know, pulled in some of their claws
- 25:54Speaker 1: a little bit when the Justice Department started poking around.
- 25:58Speaker 1: Maybe Facebook and Google and Amazon for that matter, um
- 26:02Speaker 1: throttle back a little bit. Apple's got a ton of
- 26:05Speaker 1: criticism for their thirty tax on the app store. Let's
- 26:09Speaker 1: see if anybody wants to change, uh their current business
- 26:13Speaker 1: models to sort of keep the wolves away from you know,
- 26:19Speaker 1: the crown jewels, verry. When when we do come out
- 26:22Speaker 1: of I'll put the glass half empty on on the
- 26:25Speaker 1: table here. When we do come out of this pandemic
- 26:27Speaker 1: and the economy starts to really right itself, do you
- 26:30Speaker 1: expect investors will rotate out of these tech winners and
- 26:35Speaker 1: try to find some more value and possible performance from
- 26:39Speaker 1: some of the more UH names that were beaten down
- 26:41Speaker 1: the cyclicals and so on. You know, we've done a
- 26:43Speaker 1: couple of studies on this internally. We've We've crunched a
- 26:46Speaker 1: lot of numbers, and I've read other studies from people
- 26:50Speaker 1: like Bill Miller and Research Affiliates and a q R
- 26:54Speaker 1: and go down the list. The key determiner as to
- 26:58Speaker 1: whether it's value or growth that dominates seems to be
- 27:02Speaker 1: some combination of interest rates and inflation. When we are
- 27:07Speaker 1: in a low yield environment and a very low inflationary environment,
- 27:12Speaker 1: it does not work to the advantage of value, and
- 27:15Speaker 1: in many ways the cheap cost of capital works to
- 27:19Speaker 1: the advantage of the bigger, more ambitious tech companies. But
- 27:24Speaker 1: if people like j Professor Jeremy Siegel at Wharton are correct,
- 27:27Speaker 1: and when we begin to recover and all this pent
- 27:30Speaker 1: up demands plus all the FED and congressional stimulus works
- 27:35Speaker 1: its way into the economy, you might see a little
- 27:37Speaker 1: bump up in inflation. And if it gets to three
- 27:40Speaker 1: or four percent or more for just a year a
- 27:42Speaker 1: couple of years, that should be advantageous to value stocks.
- 27:49Speaker 1: Very briefly, you know, at Redults well as management, are
- 27:52Speaker 1: you buying or selling anything these days? No, We're pretty
- 27:55Speaker 1: happy with the way our portfolios are configured. The most
- 27:59Speaker 1: recent change we made was last quarter when we added
- 28:02Speaker 1: gold to our tactical portfolio, and that that was a
- 28:08Speaker 1: pretty easy call to make when you look at the
- 28:10Speaker 1: possibility of inflation, and you look at the just the
- 28:14Speaker 1: overall trend and then the breakout in gold. But the
- 28:17Speaker 1: thing that's been driving gold recently has been the inability
- 28:22Speaker 1: for the US Congress to agree on any sort of
- 28:25Speaker 1: a second act to the Cares Act. Compared to Europe.
- 28:30Speaker 1: Look at how successfully Europe put through a new stimulus plan,
- 28:34Speaker 1: and just look at the relationship between the euro and
- 28:37Speaker 1: the dollar. The euro was having one of its best
- 28:39Speaker 1: runs in a long time. The dollar did take until
- 28:42Speaker 1: five in the morning that last day, though, So Barry,
- 28:44Speaker 1: we'll see what happens on Friday. Maybe we'll get something
- 28:46Speaker 1: out of Congress. Barry Riddles with Golden seventy ounce right now.
- 28:51Speaker 1: Thank you for joining us. Barry Riddles, CEO of Riddle's
- 28:54Speaker 1: Wealth Management, Bloomberg Opinion contributor and Masters in business host.
- 29:00Speaker 1: Thanks for listening to the Bloomberg Markets podcast. You can
- 29:02Speaker 1: subscribe and listen to interviews at Apple Podcasts or whatever
- 29:06Speaker 1: podcast platform you prefer. I'm Bonnie Quinn, I'm on Twitter
- 29:10Speaker 1: at Bonnie Quinn, and I'm Paul Sweeney. I'm on Twitter
- 29:12Speaker 1: at pt Sweeney. Before the podcast, you can always catch
- 29:15Speaker 1: us worldwide at Bloomberg Radio